Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Proper medication management is crucial in metastatic colorectal cancer because of its substantially low survival rate. There has been advancing evidence on the efficacy of the two most prescribed targeted agents (bevacizumab and cetuximab); however, comprehensive analyses on their safety are limite...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Yu Na, Choi, Yeo Jin, Rhie, Sandy Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871808/
https://www.ncbi.nlm.nih.gov/pubmed/35206832
http://dx.doi.org/10.3390/healthcare10020217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871808/
https://www.ncbi.nlm.nih.gov/pubmed/35206832
http://dx.doi.org/10.3390/healthcare10020217

Ejemplares similares